Rogaratinib: Clinical Trials

1 trial of Rogaratinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Rogaratinib: new trials by email Literature Review of Rogaratinib trials Research Report on Rogaratinib

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Rogaratinib (BAY1163877), Chemotherapy - Carcinoma, Transitional Cell
Phase 2 / Phase 3CompletedBayer1752018-05-312022-09-28

Conditions studied

Carcinoma, Transitional Cell (1)

Sponsors

Bayer (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)

Results publications

PMID 30807645, PMID 36240478

NIH funding

2016 (1)